ICON-PLC
United States
150 articles about ICON-PLC
-
ICON plc to Present at Upcoming March 2024 Investor Conferences
2/26/2024
ICON plc announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen 44th Annual Healthcare Conference on Tuesday, March 5, 2024 at 11:10 am ET and Dr. Steve Cutler, CEO of ICON plc, will present at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 2:05 pm ET.
-
ICON Reports Fourth Quarter and Full Year 2023 Results
2/21/2024
ICON plc reported its financial results for the fourth quarter and year ended December 31, 2023.
-
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
1/30/2024
ICON plc announced that it will release its financial results for the fourth quarter and full year 2023 results after the market closes on Wednesday, February 21, 2024.
-
ICON Issues Financial Guidance for Full Year 2024
1/9/2024
ICON plc, a world-leading clinical research organization powered by healthcare intelligence, announced its financial guidance for the year ending December 31, 2024.
-
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
1/8/2024
ICON plc, a world-leading healthcare intelligence and clinical research organisation, launched its “Optimising biotech funding” whitepaper.
-
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
1/4/2024
ICON plc today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15pm PST/8.15pm EST.
-
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
12/18/2023
ICON plc, a world-leading healthcare intelligence and clinical research organisation, finishes the second half of 2023 with positive recognition as a top-rated employer and leader in clinical trial innovation.
-
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
12/7/2023
ICON plc, a world-leading healthcare intelligence and clinical research organization, announced that Moody's Investors Service upgraded all of ICON plc’s instrument ratings to Baa3 with a stable outlook.
-
ICON Reports Third Quarter 2023 Results
10/25/2023
ICON plc, a world-leading healthcare intelligence and clinical research organization, reported its financial results for the third quarter ended September 30, 2023.
-
ICON Secures Upgraded Credit Rating from S&P Global Ratings
10/12/2023
ICON plc, a world-leading healthcare intelligence and clinical research organization, announced that S&P Global Ratings upgraded ICON to an investment grade credit rating of BBB- with a stable outlook, based on operating performance and deleveraging.
-
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
9/21/2023
ICON plc, a world-leading healthcare intelligence and clinical research organization, announced that it will release its financial results for the third quarter 2023 after the market closes on Wednesday, October 25, 2023.
-
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
9/20/2023
ICON plc, a world-leading healthcare intelligence and clinical research organisation, announces the release of its next generation Clinical Trial Tokenisation solution.
-
ICON plc Schedules Second Quarter 2023 Earnings Conference Call
6/27/2023
ICON plc announced that it will release its financial results for the second quarter 2023 after the market closes on Wednesday, July 26, 2023.
-
ICON plc Set to Join Russell 3000® Index
6/26/2023
ICON plc, is set to join the broad-market Russell 3000® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens , Monday, June 26.
-
ICON plc to Attend Upcoming Investor Conferences
5/31/2023
ICON plc announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 2:40pm CT and Mr. Brendan Brennan, CFO of ICON plc, will attend the UBS Healthcare Services Conference on Wednesday, June 28, 2023.
-
ICON Reports First Quarter 2023 Results
4/26/2023
ICON plc, a world-leading healthcare intelligence and clinical research organization, reported its financial results for the first quarter ended March 31, 2023.
-
ICON plc Schedules First Quarter 2023 Earnings Conference Call
3/29/2023
ICON plc announced that it will release its financial results for the first quarter 2023 after the market closes on Wednesday, April 26, 2023.
-
LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
3/10/2023
LEO Pharma and ICON plc announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient clinical portfolio execution organisations in the industry.
-
ICON plc to Present at Upcoming March 2023 Investor Conferences
2/27/2023
ICON plc, a world-leading clinical research organisation powered by healthcare intelligence, announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2023 Citi Healthcare Conference on Thursday, March 2, 2023 at 2pm ET.
-
ICON Reports Fourth Quarter and Full Year 2022 Results
2/22/2023
ICON plc, a world-leading healthcare intelligence and clinical research organization, reported its financial results for the fourth quarter and year ended December 31, 2022.